313 related articles for article (PubMed ID: 22475555)
21. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
22. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival of peritoneal carcinomatosis of colorectal origin.
Verwaal VJ; van Ruth S; Witkamp A; Boot H; van Slooten G; Zoetmulder FA
Ann Surg Oncol; 2005 Jan; 12(1):65-71. PubMed ID: 15827780
[TBL] [Abstract][Full Text] [Related]
24. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
25. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.
Marcotte E; Sideris L; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Dubé P
Ann Surg Oncol; 2008 Oct; 15(10):2701-8. PubMed ID: 18654822
[TBL] [Abstract][Full Text] [Related]
26. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
[TBL] [Abstract][Full Text] [Related]
27. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
Kianmanesh R; Scaringi S; Sabate JM; Castel B; Pons-Kerjean N; Coffin B; Hay JM; Flamant Y; Msika S
Ann Surg; 2007 Apr; 245(4):597-603. PubMed ID: 17414609
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.
Shen P; Hawksworth J; Lovato J; Loggie BW; Geisinger KR; Fleming RA; Levine EA
Ann Surg Oncol; 2004 Feb; 11(2):178-86. PubMed ID: 14761921
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience.
Füzün M; Sökmen S; Terzi C; Canda AE
Acta Chir Iugosl; 2006; 53(2):17-21. PubMed ID: 17139879
[TBL] [Abstract][Full Text] [Related]
30. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Aarts F; Hendriks T; Boerman OC; Koppe MJ; Oyen WJ; Bleichrodt RP
Ann Surg Oncol; 2007 Nov; 14(11):3274-82. PubMed ID: 17653591
[TBL] [Abstract][Full Text] [Related]
31. [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].
Glockzin G; Ghali N; Lang SA; Agha A; Schlitt HJ; Piso P
Chirurg; 2007 Dec; 78(12):1100, 1102-6, 1108-10. PubMed ID: 17992490
[TBL] [Abstract][Full Text] [Related]
32. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.
Witkamp AJ; de Bree E; Kaag MM; Boot H; Beijnen JH; van Slooten GW; van Coevorden F; Zoetmulder FA
Eur J Cancer; 2001 May; 37(8):979-84. PubMed ID: 11334722
[TBL] [Abstract][Full Text] [Related]
33. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.
Yan TD; Black D; Savady R; Sugarbaker PH
J Clin Oncol; 2006 Aug; 24(24):4011-9. PubMed ID: 16921055
[TBL] [Abstract][Full Text] [Related]
34. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features.
Portilla AG; Sugarbaker PH; Chang D
World J Surg; 1999 Jan; 23(1):23-9. PubMed ID: 9841759
[TBL] [Abstract][Full Text] [Related]
35. Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin.
Verwaal VJ
Cancer Treat Res; 2007; 134():291-301. PubMed ID: 17633061
[No Abstract] [Full Text] [Related]
36. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin.
de Bree E; Romanos J; Michalakis J; Relakis K; Georgoulias V; Melissas J; Tsiftsis DD
Anticancer Res; 2003; 23(3C):3019-27. PubMed ID: 12926156
[TBL] [Abstract][Full Text] [Related]
37. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
Pestieau SR; Sugarbaker PH
Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
[TBL] [Abstract][Full Text] [Related]
38. External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy.
Kozman MA; Fisher OM; Liauw W; Morris DL; Cashin PH
J Surg Oncol; 2023 Dec; 128(7):1150-1159. PubMed ID: 37602499
[TBL] [Abstract][Full Text] [Related]
39. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
Carmignani CP; Ortega-Perez G; Sugarbaker PH
Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.
Glehen O; Mohamed F; Gilly FN
Lancet Oncol; 2004 Apr; 5(4):219-28. PubMed ID: 15050953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
